Clinical trial
Uterine Artery Occlusion for Fibroid Related Bleeding
NCT00496067 · Ethicon, Inc., Industry · Terminated
Key facts
| NCT number | NCT00496067 |
|---|---|
| Title | Uterine Artery Occlusion for Fibroid Related Bleeding |
| Official title | An Evaluation of a Doppler-Guided Uterine Artery Occlusion Device as Treatment for the Reduction of Fibroid-Associated Bleeding |
| Lead sponsor | Ethicon, Inc., Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Menorrhagia, Uterine Fibroids |
| Intervention type | Device |
| Interventions | Doppler-Guided Uterine Artery Occlusion Device |
| Enrollment | 91 |
| Start date | Apr 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jul 4, 2007 |
| Last update posted | Mar 9, 2011 |
| Countries | Denmark, France, Germany, Netherlands, Norway, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: